Elevated ASF1B expression was linked to poorer OS in ACC, KIRC, KIRP, LGG, LIHC, LUAD, Mesothelioma (MESO), and Pancreatic adenocarcinoma (PAAD), whereas it was associated with better OS in Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), STAD, and Thymoma (THYM) patients (Figure 2A). Here, ASF1B is linked to pancreatic adenocarcinoma.